Logo image of AKE.PA

ARKEMA (AKE.PA) Stock Fundamental Analysis

EPA:AKE - FR0010313833 - Common Stock

57.55 EUR
+0.25 (+0.44%)
Last: 9/5/2025, 9:12:37 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AKE. AKE was compared to 68 industry peers in the Chemicals industry. AKE has only an average score on both its financial health and profitability. AKE has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AKE was profitable.
AKE had a positive operating cash flow in the past year.
Each year in the past 5 years AKE has been profitable.
Each year in the past 5 years AKE had a positive operating cash flow.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

AKE has a Return On Assets (1.51%) which is comparable to the rest of the industry.
AKE has a Return On Equity of 2.90%. This is comparable to the rest of the industry: AKE outperforms 52.94% of its industry peers.
With a Return On Invested Capital value of 3.44%, AKE perfoms like the industry average, outperforming 54.41% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AKE is in line with the industry average of 7.11%.
Industry RankSector Rank
ROA 1.51%
ROE 2.9%
ROIC 3.44%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

AKE has a Profit Margin (2.22%) which is comparable to the rest of the industry.
AKE's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 6.35%, AKE perfoms like the industry average, outperforming 55.88% of the companies in the same industry.
In the last couple of years the Operating Margin of AKE has declined.
The Gross Margin of AKE (19.02%) is worse than 75.00% of its industry peers.
AKE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.35%
PM (TTM) 2.22%
GM 19.02%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AKE is creating some value.
Compared to 1 year ago, AKE has more shares outstanding
AKE has less shares outstanding than it did 5 years ago.
AKE has a worse debt/assets ratio than last year.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 1.90 indicates that AKE is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of AKE (1.90) is worse than 61.76% of its industry peers.
The Debt to FCF ratio of AKE is 16.70, which is on the high side as it means it would take AKE, 16.70 years of fcf income to pay off all of its debts.
AKE has a Debt to FCF ratio (16.70) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.50 indicates that AKE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.50, AKE perfoms like the industry average, outperforming 44.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.7
Altman-Z 1.9
ROIC/WACC0.69
WACC4.96%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

AKE has a Current Ratio of 2.73. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
AKE's Current ratio of 2.73 is fine compared to the rest of the industry. AKE outperforms 79.41% of its industry peers.
AKE has a Quick Ratio of 1.92. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
AKE has a better Quick ratio (1.92) than 85.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.92
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

3

3. Growth

3.1 Past

AKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.85%.
Measured over the past 5 years, AKE shows a small growth in Earnings Per Share. The EPS has been growing by 0.10% on average per year.
The Revenue has been growing slightly by 0.19% in the past year.
The Revenue has been growing slightly by 1.78% on average over the past years.
EPS 1Y (TTM)-24.85%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-45.26%
Revenue 1Y (TTM)0.19%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-5.56%

3.2 Future

The Earnings Per Share is expected to grow by 2.75% on average over the next years.
Based on estimates for the next years, AKE will show a small growth in Revenue. The Revenue will grow by 1.26% on average per year.
EPS Next Y-28.82%
EPS Next 2Y-7.02%
EPS Next 3Y-0.18%
EPS Next 5Y2.75%
Revenue Next Year-2.98%
Revenue Next 2Y0.09%
Revenue Next 3Y1.44%
Revenue Next 5Y1.26%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.02, the valuation of AKE can be described as very reasonable.
Based on the Price/Earnings ratio, AKE is valued cheaper than 94.12% of the companies in the same industry.
When comparing the Price/Earnings ratio of AKE to the average of the S&P500 Index (27.03), we can say AKE is valued rather cheaply.
The Price/Forward Earnings ratio is 8.11, which indicates a very decent valuation of AKE.
Based on the Price/Forward Earnings ratio, AKE is valued cheaper than 97.06% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AKE to the average of the S&P500 Index (22.63), we can say AKE is valued rather cheaply.
Industry RankSector Rank
PE 9.02
Fwd PE 8.11
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKE is valued cheaply inside the industry as 95.59% of the companies are valued more expensively.
AKE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AKE is cheaper than 76.47% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.28
EV/EBITDA 4.75
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)92.3
EPS Next 2Y-7.02%
EPS Next 3Y-0.18%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.87%, AKE is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.08, AKE pays a better dividend. On top of this AKE pays more dividend than 92.65% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, AKE pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.87%

5.2 History

The dividend of AKE is nicely growing with an annual growth rate of 6.86%!
Dividend Growth(5Y)6.86%
Div Incr Years4
Div Non Decr Years4
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

AKE pays out 129.52% of its income as dividend. This is not a sustainable payout ratio.
AKE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP129.52%
EPS Next 2Y-7.02%
EPS Next 3Y-0.18%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (9/5/2025, 9:12:37 AM)

57.55

+0.25 (+0.44%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-07 2025-11-07
Inst Owners55.8%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap4.38B
Analysts75.24
Price Target78.74 (36.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.87%
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-5.78%
PT rev (3m)-18.79%
EPS NQ rev (1m)-7.4%
EPS NQ rev (3m)-42.1%
EPS NY rev (1m)-26.83%
EPS NY rev (3m)-26.83%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)-11.64%
Revenue NY rev (1m)-0.8%
Revenue NY rev (3m)-4.55%
Valuation
Industry RankSector Rank
PE 9.02
Fwd PE 8.11
P/S 0.46
P/FCF 19.28
P/OCF 4.31
P/B 0.61
P/tB 2.04
EV/EBITDA 4.75
EPS(TTM)6.38
EY11.09%
EPS(NY)7.1
Fwd EY12.33%
FCF(TTM)2.98
FCFY5.19%
OCF(TTM)13.36
OCFY23.21%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)92.3
Profitability
Industry RankSector Rank
ROA 1.51%
ROE 2.9%
ROCE 4.88%
ROIC 3.44%
ROICexc 3.86%
ROICexgc 7.22%
OM 6.35%
PM (TTM) 2.22%
GM 19.02%
FCFM 2.4%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexcg growth 3Y-19.33%
ROICexcg growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.7
Debt/EBITDA 2.56
Cap/Depr 95.75%
Cap/Sales 8.36%
Interest Coverage 17.14
Cash Conversion 71.35%
Profit Quality 108.1%
Current Ratio 2.73
Quick Ratio 1.92
Altman-Z 1.9
F-Score5
WACC4.96%
ROIC/WACC0.69
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-24.85%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-45.26%
EPS Next Y-28.82%
EPS Next 2Y-7.02%
EPS Next 3Y-0.18%
EPS Next 5Y2.75%
Revenue 1Y (TTM)0.19%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-5.56%
Revenue Next Year-2.98%
Revenue Next 2Y0.09%
Revenue Next 3Y1.44%
Revenue Next 5Y1.26%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year69.34%
EBIT Next 3Y25.14%
EBIT Next 5Y15.99%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%